Digital Pathology
Owkin, AstraZeneca Partner to Develop AI-Based Breast Cancer Prescreening Tool
The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.
Io9 AI-Driven Digital Pathology Test Shows Potential to Inform Breast, Ovarian Cancer Therapy
Premium
The firm hopes to develop its DeepHRD digital pathology test as an alternative to costly companion diagnostics based on next-generation sequencing.
BioAI, Genomic Testing Cooperative Collaborate to Support Pharmas, Clinicians
The companies will leverage their joint AI capabilities to advance biomarker development and both tissue and liquid biopsy genomic profiling assays.
Nucleai to Integrate Predictive Biomarker Tech Into Proscia Digital Pathology Platform
The companies will integrate Nucleai's technologies into Proscia's cloud-based Concentriq digital pathology platform.
Nucleai, GoPath Diagnostics Collaborating on Digital Pathology Tools
The companies plan to develop digital pathology tools for clinical trials and AI-based diagnostics in areas including oncology and immunology.